Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)

SHE:300957 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,574	1,810	2,091	2,514	2,035	751.95
Short-Term Investments	-	-	310	480.12	1,530	-
Trading Asset Securities	2,367	2,428	1,238	1,434	781.15	-
Cash & Short-Term Investments	3,941	4,239	3,640	4,428	4,346	751.95
Cash Growth	25.39%	16.45%	-17.80%	1.89%	477.93%	42.62%
Accounts Receivable	738.07	1,047	742.92	508.76	328.3	326.48
Other Receivables	41.67	173.14	157.87	20.47	37.81	19.33
Receivables	779.74	1,220	900.79	529.23	366.11	345.81
Inventory	775.78	611.89	904.41	670.75	463.27	253.75
Prepaid Expenses	-	6.95	6.98	-	2.92	5.25
Other Current Assets	220.8	55.31	70.57	87.01	46.95	34.41
Total Current Assets	5,717	6,133	5,523	5,715	5,225	1,391
Property, Plant & Equipment	860.13	936.82	808.14	665.36	431.96	109.29
Long-Term Investments	442.33	375.95	298.46	82.78	-	-
Goodwill	323.05	323.05	413.74	-	-	-
Other Intangible Assets	559.41	258.52	193.11	77.94	64.59	55.16
Long-Term Deferred Tax Assets	144.42	129.34	93.13	52.12	15.58	13.35
Long-Term Deferred Charges	113.86	113.59	93.32	66.73	41.02	20.36
Other Long-Term Assets	41.47	33.38	84.45	59.63	34.31	12.53
Total Assets	8,202	8,304	7,507	6,720	5,812	1,602
Accounts Payable	566.91	447.18	401.93	372.37	361.61	134.84
Accrued Expenses	100.45	457.76	469.93	312.06	285.73	150.21
Short-Term Debt	453.13	314.56	103.82	-	-	-
Current Portion of Leases	72.35	63.33	42.1	62.42	48.91	-
Current Income Taxes Payable	96.11	70	105.22	109.69	97.54	65.78
Current Unearned Revenue	81.51	98.97	50.05	58.12	71.19	36.5
Other Current Liabilities	200.81	66.13	118.16	77.21	34.78	3.86
Total Current Liabilities	1,571	1,518	1,291	991.87	899.75	391.19
Long-Term Debt	207.96	321.66	4.7	-	-	-
Long-Term Leases	81.58	118.23	63.28	50.95	76.29	-
Long-Term Unearned Revenue	90.43	112.37	82.86	55.57	6.3	7.41
Long-Term Deferred Tax Liabilities	22.09	33.3	40.45	8.36	1.69	-
Other Long-Term Liabilities	7.41	12.25	8.6	10.5	50	1.45
Total Liabilities	1,981	2,116	1,491	1,117	1,034	400.05
Common Stock	423.6	423.6	423.6	423.6	423.6	360
Additional Paid-In Capital	2,828	2,817	2,846	2,846	2,846	25.71
Retained Earnings	2,971	2,952	2,701	2,283	1,486	813.3
Treasury Stock	-144.96	-144.96	-109.84	-	-	-
Comprehensive Income & Other	1.72	2.05	0.05	-0	0	-
Total Common Equity	6,080	6,050	5,861	5,553	4,755	1,199
Minority Interest	141.24	137.92	154.82	49.48	23.26	2.81
Shareholders' Equity	6,221	6,188	6,016	5,602	4,778	1,202
Total Liabilities & Equity	8,202	8,304	7,507	6,720	5,812	1,602
Total Debt	815.02	817.77	213.9	113.36	125.2	-
Net Cash (Debt)	3,126	3,421	3,426	4,315	4,221	751.95
Net Cash Growth	30.74%	-0.14%	-20.60%	2.23%	461.28%	46.79%
Net Cash Per Share	7.38	8.16	8.10	10.18	10.37	2.09
Filing Date Shares Outstanding	419.95	421.29	420.61	423.6	423.6	423.6
Total Common Shares Outstanding	419.95	421.29	420.61	423.6	423.6	360
Working Capital	4,146	4,615	4,231	4,723	4,325	999.98
Book Value Per Share	14.48	14.36	13.93	13.11	11.23	3.33
Tangible Book Value	5,197	5,468	5,254	5,475	4,691	1,144
Tangible Book Value Per Share	12.38	12.98	12.49	12.92	11.07	3.18
Buildings	-	251.48	261.2	50.35	33.8	33.8
Machinery	-	649.81	527.8	228.01	124.7	68.73
Construction In Progress	-	50.76	40.22	349.47	197.29	40.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.